Streetbeat News

AXR

AMREP Corporation

https://amrepcorp.com

Industry

Real Estate - Development

AMREP Corporation, through its subsidiaries, primarily engages in the real estate business. The company operates through two segments, Land Development and Homebuilding. The company sells developed and undeveloped lots to homebuilders, commercial and industrial property developers, and others. As of July 1, 2022, it owned approximately 17,000 acres in Sandoval County, New Mexico. The company owns an approximately 160-acre property in Brighton, Colorado. It also owns mineral interests covering an area of approximately 55,000 surface acres of land in Sandoval County, New Mexico; and owns oil, gas, and minerals and mineral interests covering an area of approximately 147 surface acres of land in Brighton, Colorado. Additionally, the company focuses on selling single-family detached homes and attached homes. AMREP Corporation was founded in 1961 and is headquartered in Havertown, Pennsylvania.

Open

31.39

Mkt cap

163M

Volume

7.2K

High

31.53

P/E Ratio

17.51

52-wk high

32.05

Low

30.81

Div yield

N/A

52-wk low

15.38

Insiders at Lovesac Company, Postal Realty Trust, Sonida Senior Living, and AMREP have made notable purchases of their company's stock, signaling confidence in their respective companies' prospects. These transactions include significant investments by directors and CEOs, with the backdrop of various company performances and analyst ratings.

Portfolio Pulse from Avi Kapoor

April 19, 2024 | 11:29 am

Insiders have made notable purchases in shares of General American Investors Company (GAM), AMREP Corporation (AXR), and Ares Commercial Real Estate (ACRE), indicating their confidence in these companies. AMREP reported a significant decrease in earnings per share in its fiscal third quarter of 2024 compared to the previous year. Ares Commercial Real Estate received a downgrade from B of A Securities, with a lowered price target. General American Investors has seen an 8% stock increase year-to-date.

Portfolio Pulse from Avi Kapoor

April 05, 2024 | 12:53 pm

U.S. stock futures are trading lower, with focus on Fortrea Holdings, Oracle, AMREP, Calavo Growers, and Casey's General Stores due to earnings reports. Fortrea and AMREP have already reported, while Oracle, Calavo Growers, and Casey's are expected to report after the market closes. Fortrea and AMREP shares saw gains in after-hours and previous close, respectively, while Oracle and Casey's experienced slight movements, and Calavo Growers shares increased.

Portfolio Pulse from Avi Kapoor

March 11, 2024 | 8:38 am

Amrep (NYSE:AXR) reported a significant decrease in its quarterly earnings per share (EPS) to $0.02, down from $3.12 YoY, despite a 39.18% increase in sales to $12.69M from $9.12M YoY.

Portfolio Pulse from Benzinga Newsdesk

March 08, 2024 | 9:55 pm

$320M Bet On This Healthcare Stock? Check Out These 3 Stocks Insiders Are Buying. Notable insider purchases were made in Arcus Biosciences, Peoples Financial, and AMREP, indicating confidence in these companies. Gilead Sciences Inc acquired shares of Arcus Biosciences for $320 million. Peoples Financial CEO bought shares worth $81,568. AMREP saw a purchase of $891,020 by Rainey Lancaster.

Portfolio Pulse from Avi Kapoor

February 01, 2024 | 11:09 am

Insiders at FB Financial Corporation and AMREP Corporation have made notable stock purchases. FB Financial's 10% owner James Ayers bought 2,000 shares at $38.20 each, while AMREP's 10% owner Rainey Lancaster acquired 1,800 shares at $21.82 each. These insider trades suggest confidence in the companies' prospects. However, FB Financial was recently downgraded by Hovde Group analyst Brett Rabatin, and AMREP reported a decline in quarterly sales.

Portfolio Pulse from Avi Kapoor

January 24, 2024 | 11:57 am

Insiders at Talos Energy, PBF Energy, AMREP, and KalVista Pharmaceuticals have made significant stock purchases. Talos Energy's 10% owner bought shares worth $230 million, while PBF Energy's 10% owner purchased $20.78 million in stock. AMREP's 10% owner acquired shares for $153,384, and KalVista Pharmaceuticals' 10% owner invested $1.8 million. These transactions may indicate insider confidence despite varying company news, such as Talos Energy's public offering, a downgrade for PBF Energy, a sales decline for AMREP, and new research publication for KalVista Pharmaceuticals.

Portfolio Pulse from Avi Kapoor

January 22, 2024 | 11:41 am

Insiders at Solid Biosciences, Champions Oncology, and AMREP Corporation have made notable stock purchases. Solid Biosciences insiders acquired over 4 million shares, coinciding with a private placement deal. Champions Oncology's director bought shares after a reported loss, and AMREP's 10% owner invested following a sales decline. Insider buying can signal confidence in the company's future or undervaluation, potentially indicating a buying opportunity, though it should not be the sole investment decision factor.

Portfolio Pulse from Avi Kapoor

January 16, 2024 | 11:17 am

Insiders at AMREP Corporation, NB Bancorp, Inc., and VOXX International Corporation have made significant stock purchases, signaling potential confidence in their respective companies. AMREP's 10% owner bought shares despite a decline in quarterly sales. NB Bancorp's EVP acquired shares as the stock saw a slight gain over five days. VOXX International's Director made a substantial purchase following a settlement agreement with Seaguard.

Portfolio Pulse from Avi Kapoor

January 09, 2024 | 1:17 pm

Insiders at AMREP, FedEx, Synchronoss Technologies, and Greif have made notable stock purchases, signaling confidence in their respective companies. AMREP's 10% owner bought shares despite a sales decline. FedEx's CFO invested amidst a $1 billion share repurchase agreement. Synchronoss Technologies' director made a purchase after regaining Nasdaq compliance. Greif's EVP and CFO bought shares following strong quarterly earnings.

Portfolio Pulse from Avi Kapoor

December 29, 2023 | 2:20 pm

All corporate logos and prices are for illustrative purposes only and are not a recommendation, an offer to sell, or a solicitation of an offer to buy any security.